 Life Science Investor Mandates (May 12 - May 18)
|
|
|
Seeks Novel Therapeutic Platforms From Preclinical-Phase II
|
Focuses New Fund On Healthcare IT Deals
|
Invests in Therapeutics in Oncology, Ophthalmology, and Nephrology from Preclinical Onwards
|
Raises New Therapeutics Fund Targeting Clinical Stage Drugs
|
|
|
Put The Spotlight On Your Company in the RESI Innovation Challenge
|
Every 90 days, RESI gathers hundreds of active early stage life science investors for a one-day partnering event. RESI Innovation Challenge finalists are provided with an all day showcase to attract the attention of those investors using their branding and messaging. It's a unique opportunity to be a featured company in the life sciences industry. All applicants are vetted by LSN's scientific review team, with a view to not just the quality of the company's scientific work, but also the strength of the management team and how well-positioned the company is to receive investment.
What makes the RESI Innovation Challenge so valuable? We've included a few words from previously successful participants below, but in short, being part of the Innovation Challenge provides startups with a new way to get attention and start dialogues with the investors who attend RESI. Participants can share their message all day in the exhibit hall, with their Innovation Challenge display providing a starting point for a meaningful conversation about the opportunity. Here is what our previous winners are saying about the RESI Innovation Challenge: "I love the RESI Innovation Challenge because it is a great way to give our pitch to practice it and try to obtain a scarce resource from these investors. Practicing with these investors is a great way to build relationships and continue that on to the real investment conversations."
- Niko Skievaski, Co-Founder, Redox
"The RESI Innovation Challenge is a really good opportunity to meet investors and other companies in the space. It's a good showcase to reach that audience."
- Jessica Ching, CEO, Eve Medical
2nd Place, RESI San Francisco, January 12, 2016
"The RESI Innovation Challenge is a unique way to pitch, and provides a great opportunity to see what other companies are doing in the industry, while allowing you to meet with potential investors and strategic partners outside of the partnering meetings."
- John Connolly, VP Corporate Development, Rna Diagnostics
1st Place, RESI Boston, September 16, 2015
"RESI offers small companies like GeneSegues a direct line to potential partners and potential investors in a small setting conducive to relationship building and conversation. The Innovation Challenge was a particularly great way to introduce our company to a broader audience than I could meet with personally which allowed us to leverage the showcasing of our technology more efficiently."
-Laura M. Brod,Chief Executive Officer,GeneSegues Therapeutics
-1st Place, RESI @TMCx, April 11, 2016
|
 |
1st Place
|
Laura Brod, CEO, GeneSegues
|
2nd Place
|
Austin Dirks, CEO & CO-Founder, GreenLight Medical
|
3rd Place
|
Alexander Schüller, President, Adhesys
|
|
RESI San Francisco January 12, 2016
1st Place
|
Shravanthi Reddy, COO, ClearSight
|
2nd Place
|
Jessica Ching, CEO, Eve Medical
|
3rd Place
|
Jonathan W. Gunn, JD, PhD, CEO & Co-founder. Briteseed
|
|
RESI Boston September 16, 2015
1st Place
|
Jonathan W. Gunn, JD, PhD, CEO & Co-founder, Rna Diagnostics
|
2nd Place
|
Matthew R. Gevaert, Ph.D. CEO & Co-founder
|
3rd Place
|
Kenneth J. Slepicka, CEO & Director
|
|
1st Place
|
Niko Skievaski, Co-founder, Redox
|
2nd Place
|
Wade Lange, CEO, NeuroFx
|
3rd Place
|
Laura Bosworth, CEO & co-founder, TeVido BioDevices
|
|
RESI San Francisco January 13, 2015
1st Place
|
Shawn Iadonato, Ph.D., CEO, Kineta
|
2nd Place
|
Eric Goslau, CEO, Transverse Medical
|
3rd Place
|
Robert Thompson, President & CEO, Amorphex Therapeutics
|
|
RESI Boston September 17, 2014
1st Place
|
Robin Smith, CEO, ORIG3N
|
2nd Place
|
Jeff Missling, CEO, SpineThera
|
3rd Place
|
Kurt Dieck, President & CEO, Biosortia
|
|
RESI Boston March 24, 2014
1st Place
|
Pam Randhawa, Founder & CEO, EMPIRIKO
|
2nd Place
|
Marcia Fournier, CEO, BIOARRAY
|
3rd Place
|
Magdalena Leszczyniecka, President & CEO, STC Biologics
Tasos Smeros, Founder & CEO, Multineurons
|
|
Apply today for the chance to join!
|
|
|